ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0629

Patient and Physician Satisfaction with Telemedicine Utilization for Delivery of Care in Patients with SLE – A Single Centre Experience

Tanmayee Bichile1, Amanda Bembic2, Susan Manzi1 and Sonia Manocha1, 1Allegheny Health Network, Pittsburgh, PA, 2Allgheny Health Network, Pittsburgh, PA

Meeting: ACR Convergence 2021

Keywords: Access to care, COVID-19, Health Care, Surveys, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 7, 2021

Title: Measures & Measurement of Healthcare Quality Poster (0623–0659)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: COVID 19 has forced the healthcare system to utilize telemedicine to provide dependable and timely care for patients with SLE. Telemedicine has been used in patient care for RA, gout and CTD including SLE. Data on the use of telemedicine in patients with SLE is limited. The purpose of this study is to evaluate patient and physician satisfaction with use of telemedicine for SLE. This understanding can be utilized to provide timely access to care, improve gaps in delivery of care and address healthcare disparities.

Methods: After IRB approval,we queried EMR to identify patients with SLE (ICD10 codes M32.0-M32.9, L93.0-L93.2) seen as video visits (CPT codes 99201-99205,99211-99215) with providers in our division (Physicians and PAs= 18). Patients 18 years or older were included from 3/17/2020. Satisfaction Surveys were distributed to both patients and physicians. Chart review was performed on patient responders. A Likert scale was used to collect responses.

Results: 171 patients got the Patient satisfaction survey. 39 patients completed the survey, response rate was 22.8%. Chart review was done on 36 patients. 76.9% used telemedicine for the first time to seek care for SLE. 65.7% strongly agreed with ease to set up phone/computer. 94.8% visits started on time. 76.9% strongly agreed with visit convenience. 79.4% strongly agreed with adequate time to discuss questions/concerns . 69.2% strongly agreed with being comfortable with provider taking medical decisions. 66.6% strongly agreed with the satisfaction of the quality of care they received. 76.9% strongly agreed with the comfort of discussing problems. 47.2% patients received their telemedicine visit within a week from calling for appointment. 66.6% patients strongly agreed to another telemedicine visit but only 23.3% preferred telemedicine over in person visit. With Provider Satisfaction survey, 18 of 20 responded. 44.4% had used telemedicine to provide any medical care prior to pandemic while 22.2% had used telemedicine to provide care for SLE prior to the pandemic. 50% agreed and 22.2% strongly agreed with ease to set up hardware and software. 100% agreed that visits start on time. 61% agreed and 33.3% strongly agreed that visit was convenient. 55.5% agreed while 16.6% strongly agreed with the quality of care they provided. 100% were willing to order diagnostic and laboratory tests, prescribe medications. 61.1% were able to do some physical exam. 38.8% disagreed with preference of telemedicine over in person visit, 38.8% were neutral and 11.1% agreed and the rest 11.1% strongly disagreed.

Conclusion: Our study shows that telemedicine has an overall favorable satisfaction for SLE care among patients and providers. Our results indicate that patients with complex disease and medications and the providers could utilize telemedicine with favorable overall satisfaction. Over 50% patients had seen their rheumatologist for more than 5 years which indicates that an established patient-provider relationship is favorable for telemedicine use. Despite the overall satisfaction, both patients and providers seem to prefer an in person care over telemedicine only care for SLE.


Disclosures: T. Bichile, None; A. Bembic, None; S. Manzi, None; S. Manocha, None.

To cite this abstract in AMA style:

Bichile T, Bembic A, Manzi S, Manocha S. Patient and Physician Satisfaction with Telemedicine Utilization for Delivery of Care in Patients with SLE – A Single Centre Experience [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/patient-and-physician-satisfaction-with-telemedicine-utilization-for-delivery-of-care-in-patients-with-sle-a-single-centre-experience/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-and-physician-satisfaction-with-telemedicine-utilization-for-delivery-of-care-in-patients-with-sle-a-single-centre-experience/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology